Lupus Erythematosus, Systemic
|
0.670 |
GeneticVariation
|
disease |
BEFREE |
The identification of new mutation in C1qA gene that disrupts the start codon (ATG to AGG (Met1Arg)) has not been reported previously and it expands the knowledge and importance of the C1q gene in the pathogenesis of lupus especially in the high-risk African-American population.
|
22472776 |
2012 |
Lupus Erythematosus, Systemic
|
0.670 |
GeneticVariation
|
disease |
BEFREE |
The C1qA SNPs, rs172378 and rs665691, confer no genetic predisposition to SLE in a Chinese Han population.
|
22236909 |
2012 |
Lupus Erythematosus, Systemic
|
0.670 |
GeneticVariation
|
disease |
BEFREE |
Recent studies have tested genetic variation at the C1QA, C1QB and C1QC (complement component 1, q subcomponent, A chain, complement component 1, q subcomponent, B chain and complement component 1, q subcomponent, c chain) loci in relation to systemic lupus erythematosus (SLE) risk.
|
20528885 |
2010 |
Lupus Erythematosus, Systemic
|
0.670 |
Biomarker
|
disease |
BEFREE |
The C1QA gene is associated with subphenotypes of lupus in the African-American and Hispanic subjects.
|
19440201 |
2009 |
Lupus Erythematosus, Systemic
|
0.670 |
GeneticVariation
|
disease |
BEFREE |
Polymorphisms of the C1qA gene are associated with low serum C1q levels in patients with cutaneous LE, but C1q polymorphisms have not been studied in patients with systemic lupus.
|
18504288 |
2009 |
Lupus Erythematosus, Systemic
|
0.670 |
GeneticVariation
|
disease |
BEFREE |
Statistical analysis also revealed that there were no significant associations observed in the genotype distributions and allele frequencies among the patients with SLE and healthy control subjects with both C1qA-Gly70 (G/A) and C1qC-Pro14 (T/C) SNPs.
|
18505047 |
2008 |
Lupus Erythematosus, Systemic
|
0.670 |
GeneticVariation
|
disease |
BEFREE |
The C1qA polymorphism associated with decreased distant metastasis has also been correlated with an increased incidence of subcutaneous systemic lupus and C1q deficiencies, suggesting that an altered immune response may play a role in the observed association.
|
16465510 |
2006 |
Lupus Erythematosus, Systemic
|
0.670 |
Biomarker
|
disease |
MGD |
Central role of complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice.
|
12794146 |
2003 |
Lupus Erythematosus, Systemic
|
0.670 |
Biomarker
|
disease |
MGD |
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.
|
9590289 |
1998 |
Lupus Erythematosus, Systemic
|
0.670 |
Biomarker
|
disease |
CTD_human |
Molecular basis of hereditary C1q deficiency associated with SLE and IgA nephropathy in a Turkish family.
|
8840296 |
1996 |
Lupus Erythematosus, Systemic
|
0.670 |
Biomarker
|
disease |
HPO |
|
|
|
C1q DEFICIENCY
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
C1q: A fresh look upon an old molecule.
|
28601358 |
2017 |
C1q DEFICIENCY
|
0.610 |
GeneticVariation
|
disease |
BEFREE |
Identification of novel coding mutation in C1qA gene in an African-American pedigree with lupus and C1q deficiency.
|
22472776 |
2012 |
C1q DEFICIENCY
|
0.610 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
C1q DEFICIENCY
|
0.610 |
Biomarker
|
disease |
CTD_human |
|
|
|
Exanthema
|
0.310 |
Biomarker
|
phenotype |
BEFREE |
In a case study of exploring the mechanism of rash, we find that HLAs, C1QA and APOA1 are the key gene players and thus can be potential targets (or biomarkers) in monitoring or countermining rashes.
|
30053268 |
2018 |
Schizophrenia
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
In order to explore whether these alterations are genetically determined or not, in the present study we evaluated the possible association of complement C1Q component gene variants with susceptibility to schizophrenia in Armenian population, focusing on four frequent single nucleotide polymorphisms (SNPs) of C1QA and C1QB genes.
|
21951915 |
2011 |
Exanthema
|
0.310 |
Biomarker
|
phenotype |
CTD_human |
Molecular basis of hereditary C1q deficiency associated with SLE and IgA nephropathy in a Turkish family.
|
8840296 |
1996 |
Complement deficiency disease
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
C1q: A fresh look upon an old molecule.
|
28601358 |
2017 |
IGA Glomerulonephritis
|
0.300 |
Biomarker
|
disease |
CTD_human |
The molecular phenotype of endocapillary proliferation: novel therapeutic targets for IgA nephropathy.
|
25133636 |
2014 |
Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
SYSTEMIC LUPUS ERYTHEMATOSUS 16
|
0.300 |
SusceptibilityMutation
|
disease |
ORPHANET |
The role of complement in the development of systemic lupus erythematosus.
|
15032584 |
2004 |
IGA Glomerulonephritis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Molecular basis of hereditary C1q deficiency associated with SLE and IgA nephropathy in a Turkish family.
|
8840296 |
1996 |
Glomerulonephritis, Membranoproliferative
|
0.300 |
Biomarker
|
disease |
CTD_human |
Molecular basis of hereditary C1q deficiency associated with SLE and IgA nephropathy in a Turkish family.
|
8840296 |
1996 |
Immune Complex Diseases
|
0.300 |
Biomarker
|
group |
CTD_human |
Molecular basis of hereditary C1q deficiency associated with SLE and IgA nephropathy in a Turkish family.
|
8840296 |
1996 |